BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 3, 2003
View Archived Issues
Alvimopan Phase III Results Provide Adolor With Boost
Adolor Corp.'s stock hit a springboard, bouncing up about 31.3 percent Wednesday after the company released positive data from its first Phase III study of lead product alvimopan in the management of postoperative ileus.(BioWorld Today)
Read More
Isis Cuts Staff, Curbs Programs Following Failure Of Affinitak
Read More
Alabamian Scientists Blow Cover On HIV/AIDS Virus' Quick-Change, Vaccine Defying, Escapist Artistry
Read More
Orchid Brings In $16M Through Private Sale Of Preferred Stock
Read More
MicroIslet Secures $12M For Preclinical Trials In Diabetes
Read More
Other News To Note
Read More